1. Home
  2. PAYC vs RDY Comparison

PAYC vs RDY Comparison

Compare PAYC & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAYC
  • RDY
  • Stock Information
  • Founded
  • PAYC 1998
  • RDY 1984
  • Country
  • PAYC United States
  • RDY India
  • Employees
  • PAYC N/A
  • RDY N/A
  • Industry
  • PAYC Computer Software: Prepackaged Software
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAYC Technology
  • RDY Health Care
  • Exchange
  • PAYC Nasdaq
  • RDY Nasdaq
  • Market Cap
  • PAYC 13.2B
  • RDY 12.1B
  • IPO Year
  • PAYC 2014
  • RDY N/A
  • Fundamental
  • Price
  • PAYC $226.41
  • RDY $13.94
  • Analyst Decision
  • PAYC Hold
  • RDY Strong Buy
  • Analyst Count
  • PAYC 11
  • RDY 2
  • Target Price
  • PAYC $230.00
  • RDY $16.95
  • AVG Volume (30 Days)
  • PAYC 492.4K
  • RDY 1.6M
  • Earning Date
  • PAYC 08-06-2025
  • RDY 07-23-2025
  • Dividend Yield
  • PAYC 0.66%
  • RDY 0.51%
  • EPS Growth
  • PAYC N/A
  • RDY 2.20
  • EPS
  • PAYC 7.02
  • RDY 0.79
  • Revenue
  • PAYC $1,913,800,000.00
  • RDY $3,897,394,052.00
  • Revenue This Year
  • PAYC $10.03
  • RDY $7.61
  • Revenue Next Year
  • PAYC $9.17
  • RDY $1.89
  • P/E Ratio
  • PAYC $32.27
  • RDY $17.57
  • Revenue Growth
  • PAYC 9.87
  • RDY 15.86
  • 52 Week Low
  • PAYC $152.46
  • RDY $12.26
  • 52 Week High
  • PAYC $267.76
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • PAYC 41.03
  • RDY 33.24
  • Support Level
  • PAYC $233.15
  • RDY $14.00
  • Resistance Level
  • PAYC $238.44
  • RDY $14.86
  • Average True Range (ATR)
  • PAYC 4.49
  • RDY 0.24
  • MACD
  • PAYC 0.57
  • RDY -0.06
  • Stochastic Oscillator
  • PAYC 33.80
  • RDY 9.13

About PAYC Paycom Software Inc.

Founded in 1998, Paycom Software Inc is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: